Published in Lab Business Week, October 9th, 2005
The EOL-1 module offers health industry distributor representatives an interactive, web-based tool for accessing mandatory educational information on patients taking Coumadin (warfarin), a blood-thinning drug, and the INRatio system.
Warfarin patients must monitor the effectiveness of their therapy through regular PT/INR testing in order to guard against potentially lethal blood clots. The INRatio system measures a patient's blood-clotting time with one drop of blood from a fingerstick, giving...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.